Hanmi Pharmaceutical, Co., Ltd., headquartered in Seoul, South Korea, and established in 1973, has become one of the largest companies not only in Korea but also within the region, selling over 200 products worldwide. Today, Hanmi is also recognized as the No.1 R&D investing company in Korea, spending over 10~15% of the company’s annual revenue in developing next generation Platform Technologies & NCE products. For further information about Hanmi Pharmaceutical, please visit our website at www.hanmipharm.com.
| Website | http://www.hanmi.co.kr/ |
| Revenue | $7.9 million |
| Employees | 502 (156 on RocketReach) |
| Founded | 1973 |
| Phone | +82 31-371-5027 |
| Industry | Pharmaceutical Manufacturing, Pharmaceuticals |
| Competitors | Novartis, Merck & Co., Inc., Samsung Biologics, GSK, Amgen, Boehringer Ingelheim, LG Chem, Celltrion Inc, Daewoong Pharmaceutical, Hanmi Pharmaceuticals +39 more (view full list) |
Looking for a particular Hanmi Pharmaceuticals employee's phone or email?
Hanmi Pharmaceuticals Questions
The Hanmi Pharmaceuticals annual revenue was $7.9 million in 2026.
Chang-Ju Choi is the Vice President, Information Management Team and IR Committee of Hanmi Pharmaceuticals.
156 people are employed at Hanmi Pharmaceuticals.
Top Hanmi Pharmaceuticals Employees
-
Jeewon Shon
Vice President Clinical Research at Hanmi Pharmaceuticals
Incheon, South Korea1 -
Sungchul Choi
Director at Hanmi Pharmaceuticals
South Korea -
11
-
No-Suk Park
Director and HR at Hanmi Pharmaceuticals
Seoul, South Korea1 -
11
